Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19. Almeida GG, Pinto JA, Pinto PM, da Silva LB, et al. Vaccine 2025;64:127756.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Almeida GG, Pinto JA, Pinto PM, da Silva LB, et al. Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19. Vaccine 2025;64:127756.
PMID: 40974737